Traditional metrics obscure an expensive valuation for this Eli Lilly spinoff.
MarketWatch.com - Top Stories, MarketWatch
Wed, 09/19/2018 - 1:19pm
Traditional metrics obscure an expensive valuation for this Eli Lilly spinoff.